.After introducing a phase 3 launch based upon good midstage results, iTeos and also GSK are finally...
.The FDA must be a lot more open and collective to unleash a rise in approvals of unusual health con...
.It's an uncommonly occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bicara Reha...
.Atea Pharmaceuticals' antiviral has neglected yet another COVID-19 test, however the biotech still ...
.Neurocrine Biosciences' mental illness system pivot has stopped working. The biotech was unable to ...
.Sanofi has created an overdue entrance to the radioligand event, paying out 100 thousand euros ($ 1...
.After F2G's initial attempt to obtain a new course of antifungal to market was actually wrecked by ...
.Moderna has actually sworn to reduce R&D costs by $1.1 billion through 2027. The decision to ret...
.Simply four months after Sanofi wager $80 thousand in beforehand cash on Key Rehabs' losmapimod, th...
.Cancer company Oncternal Therapeutics is folding all its own medical trials as well as laying off s...